Dimensional Fund Advisors LP Sells 35,455 Shares of Encompass Health Co. (NYSE:EHC)

Dimensional Fund Advisors LP decreased its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,777,589 shares of the company's stock after selling 35,455 shares during the period. Dimensional Fund Advisors LP owned approximately 1.76% of Encompass Health worth $164,161,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Morse Asset Management Inc bought a new position in shares of Encompass Health in the 3rd quarter worth approximately $68,000. Tidal Investments LLC raised its holdings in Encompass Health by 5.7% in the third quarter. Tidal Investments LLC now owns 3,509 shares of the company's stock worth $339,000 after purchasing an additional 188 shares in the last quarter. Synovus Financial Corp lifted its position in Encompass Health by 92.9% during the third quarter. Synovus Financial Corp now owns 16,057 shares of the company's stock valued at $1,552,000 after buying an additional 7,733 shares during the period. Franklin Resources Inc. grew its position in shares of Encompass Health by 22.0% in the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock worth $67,412,000 after buying an additional 126,000 shares during the period. Finally, GAMMA Investing LLC increased its stake in shares of Encompass Health by 22.1% in the 4th quarter. GAMMA Investing LLC now owns 1,947 shares of the company's stock worth $180,000 after acquiring an additional 352 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on EHC. KeyCorp upped their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a report on Friday. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research report on Friday. Truist Financial reissued a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a report on Monday. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Finally, UBS Group upped their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday. Nine equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $120.86.

Encompass Health Stock Performance

Shares of NYSE:EHC traded up $0.08 during midday trading on Tuesday, reaching $115.40. 293,450 shares of the company's stock traded hands, compared to its average volume of 676,522. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a one year low of $82.38 and a one year high of $116.20. The company has a market cap of $11.62 billion, a price-to-earnings ratio of 25.86, a P/E/G ratio of 2.31 and a beta of 0.87. The stock has a 50 day moving average of $100.35 and a 200 day moving average of $98.71.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the prior year, the business earned $1.12 EPS. The business's revenue for the quarter was up 10.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.59%. Encompass Health's dividend payout ratio is presently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.